Novolin 70/30 (Insulin) for Diabetes

Overview
Novolin 70/30 is a prescription drug approved by the Food and Drug Administration (FDA) to treat diabetes. Novolin 70/30 is also referred to by its drug name, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin (rDNA origin).

Novolin 70/30 is a combination of short-acting Novolin R and intermediate-acting Novolin N.

How do I take it?
Prescribing information states that Novolin 70/30 should be administered via a subcutaneous injection. Your doctor will explain when and where you should inject Novolin 70/30 and how to measure your dosage.

Novolin 70/30 comes as a liquid in vials and cartridges for pens.

Side effects
The FDA-approved label for Novolin 70/30 lists common side effects including hypoglycemia (low blood glucose), hypokalemia (low potassium), weight gain, swelling of the extremities, lipodystrophy (fat degeneration), and minor redness or irritation at injection sites.

Rare but serious side effects listed for Novolin 70/30 can include a systemic allergic reaction and heart failure.